Literature DB >> 23284103

Species differences in the expression and activity of bone morphogenetic protein 15.

Sara L Al-Musawi1, Kelly L Walton, Derek Heath, Courtney M Simpson, Craig A Harrison.   

Abstract

Oocyte-derived bone morphogenetic protein 15 (BMP15) regulates ovulation rate and female fertility in a species-specific manner, being important in humans and sheep and largely superfluous in mice. To understand these species differences, we have compared the expression and activity of human, murine, and ovine BMP15. In HEK293F cells, human BMP15 is highly expressed (120 ng/ml), ovine BMP15 is poorly expressed (15 ng/ml), and murine BMP15 is undetectable. Because BMP15 synthesis is dependent upon interactions between the N-terminal prodomain and the C-terminal mature domain, we used site-directed mutagenesis to identify four prodomain residues (Glu(46), Glu(47), Leu(49), and Glu(50)) that mediate the high expression of human BMP15. Substituting these residues into the prodomains of murine and ovine BMP15 led to significant increases in growth factor expression; however, maximal expression was achieved only when the entire human prodomain was linked to the mature domains of the other species. Using these chimeric constructs, we produced and purified murine and ovine BMP15 and showed that in a COV434 granulosa cell bioassay, these molecules displayed little activity relative to human BMP15 (EC(50) 0.2nM). Sequence analysis suggested that the disparity in activity could be due to species differences at the type I receptor binding interface. Indeed, murine BMP15 activity was restored when specific residues through this region (Pro(329)/Tyr(330)) were replaced with the corresponding residues (Arg(329)/Asp(330)) from human BMP15. The identified differences in the expression and activity of BMP15 likely underlie the relative importance of this growth factor between species.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23284103     DOI: 10.1210/en.2012-2015

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  9 in total

1.  A variant of human growth differentiation factor-9 that improves oocyte developmental competence.

Authors:  William A Stocker; Kelly L Walton; Dulama Richani; Karen L Chan; Kiri H Beilby; Bethany J Finger; Mark P Green; Robert B Gilchrist; Craig A Harrison
Journal:  J Biol Chem       Date:  2020-04-29       Impact factor: 5.157

2.  Effects of differing oocyte-secreted factors during mouse in vitro maturation on subsequent embryo and fetal development.

Authors:  J Sudiman; L J Ritter; D K Feil; X Wang; K Chan; D G Mottershead; D M Robertson; J G Thompson; R B Gilchrist
Journal:  J Assist Reprod Genet       Date:  2014-01-11       Impact factor: 3.412

3.  Development of novel activin-targeted therapeutics.

Authors:  Justin L Chen; Kelly L Walton; Sara L Al-Musawi; Emily K Kelly; Hongwei Qian; Mylinh La; Louis Lu; George Lovrecz; Mark Ziemann; Ross Lazarus; Assam El-Osta; Paul Gregorevic; Craig A Harrison
Journal:  Mol Ther       Date:  2014-11-17       Impact factor: 11.454

4.  Regulation of AMH by oocyte-specific growth factors in human primary cumulus cells.

Authors:  Scott Convissar; Marah Armouti; Michelle A Fierro; Nicola J Winston; Humberto Scoccia; A Musa Zamah; Carlos Stocco
Journal:  Reproduction       Date:  2017-09-05       Impact factor: 3.906

5.  Cumulin, an Oocyte-secreted Heterodimer of the Transforming Growth Factor-β Family, Is a Potent Activator of Granulosa Cells and Improves Oocyte Quality.

Authors:  David G Mottershead; Satoshi Sugimura; Sara L Al-Musawi; Jing-Jie Li; Dulama Richani; Melissa A White; Georgia A Martin; Andrew P Trotta; Lesley J Ritter; Junyan Shi; Thomas D Mueller; Craig A Harrison; Robert B Gilchrist
Journal:  J Biol Chem       Date:  2015-08-08       Impact factor: 5.157

6.  Intrafollicular Concentrations of the Oocyte-secreted Factors GDF9 and BMP15 Vary Inversely in Polycystic Ovaries.

Authors:  Stine Gry Kristensen; Ajay Kumar; Linn Salto Mamsen; Bhanu Kalra; Susanne Elisabeth Pors; Jane Alrø Bøtkjær; Kirsten Tryde Macklon; Jens Fedder; Erik Ernst; Kate Hardy; Stephen Franks; Claus Yding Andersen
Journal:  J Clin Endocrinol Metab       Date:  2022-07-14       Impact factor: 6.134

7.  Concentrations of oocyte secreted GDF9 and BMP15 decrease with MII transition during human IVM.

Authors:  Jesús Cadenas; Susanne Elisabeth Pors; Ajay Kumar; Bhanu Kalra; Stine Gry Kristensen; Claus Yding Andersen; Linn Salto Mamsen
Journal:  Reprod Biol Endocrinol       Date:  2022-08-19       Impact factor: 4.982

8.  Positive selection in bone morphogenetic protein 15 targets a natural mutation associated with primary ovarian insufficiency in human.

Authors:  Sylvain Auclair; Raffaella Rossetti; Camille Meslin; Olivier Monestier; Elisa Di Pasquale; Géraldine Pascal; Luca Persani; Stéphane Fabre
Journal:  PLoS One       Date:  2013-10-16       Impact factor: 3.240

9.  Expression Analysis of the Prolific Candidate Genes, BMPR1B, BMP15, and GDF9 in Small Tail Han Ewes with Three Fecundity (FecB Gene) Genotypes.

Authors:  Jishun Tang; Wenping Hu; Ran Di; Qiuyue Liu; Xiangyu Wang; Xiaosheng Zhang; Jinlong Zhang; Mingxing Chu
Journal:  Animals (Basel)       Date:  2018-09-28       Impact factor: 2.752

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.